Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 7501-7550 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05617391
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
N/A
Active, not recruiting
1,303 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06703437
Long Acting Neuraxial Peri-prostatic Block in Cancer
PHASE1
Active, not recruiting
12 participants
Started: Dec 13, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05613647
Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
N/A
Active, not recruiting
15 participants
Started: Dec 13, 2022 · Completed: Jan 31, 2026
3 conditions
1 sponsor
1 location
NCT05677139
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
N/A
Active, not recruiting
513 participants
Started: Dec 13, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
60 locations
NCT05637801
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
NA
Active, not recruiting
670 participants
Started: Dec 13, 2022 · Completed: Jul 31, 2026
35 conditions
1 sponsor
68 locations
NCT05668988
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
PHASE3
Active, not recruiting
324 participants
Started: Dec 13, 2022 · Completed: Oct 31, 2027
1 condition
1 sponsor
160 locations
NCT05563051
Kaneka Endovascular Embolization and Protection
NA
Active, not recruiting
164 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05559580
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
PHASE2
Active, not recruiting
214 participants
Started: Dec 13, 2022 · Completed: Feb 27, 2026
1 condition
1 sponsor
167 locations
NCT05488314
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
57 participants
Started: Dec 13, 2022 · Completed: May 21, 2028
1 condition
1 sponsor
78 locations
NCT06204445
Interindividual Variation in Response to Green Coffee
NA
Active, not recruiting
120 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05659576
Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation
PHASE2
Active, not recruiting
142 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05730699
Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
PHASE3
Active, not recruiting
105 participants
Started: Dec 12, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
19 locations
NCT05690204
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
PHASE2
Active, not recruiting
87 participants
Started: Dec 12, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
16 locations
NCT05662202
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
PHASE3
Active, not recruiting
172 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
14 locations
NCT05853042
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
N/A
Active, not recruiting
1,500 participants
Started: Dec 12, 2022 · Completed: May 15, 2025
2 conditions
2 sponsors
1 location
NCT05831059
A Sympathetic Ganglion, High-voltage Pulsed Radiofrequency Ablation of Peripheral Neuralgia
NA
Active, not recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT06192667
Clinical Performance of Injectable Composite Resins in Class I Cavities
NA
Active, not recruiting
30 participants
Started: Dec 12, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT05619653
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
PHASE3
Active, not recruiting
279 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2028
7 conditions
3 sponsors
5 locations
NCT05529316
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
PHASE2
Active, not recruiting
174 participants
Started: Dec 12, 2022 · Completed: Feb 29, 2028
1 condition
1 sponsor
51 locations
NCT05254886
Identification and Management of Comorbidities and Extra-intestinal Manifestations in Crohn's Disease: the NEMO Nurse-led Program
NA
Active, not recruiting
198 participants
Started: Dec 12, 2022 · Completed: Jan 1, 2027
1 condition
1 sponsor
2 locations
NCT06325241
Validating the Use of Frailty Measurements to Predict Care & Quality of Life
N/A
Active, not recruiting
123 participants
Started: Dec 12, 2022 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT05641974
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
NA
Active, not recruiting
940 participants
Started: Dec 12, 2022 · Completed: Feb 27, 2027
2 conditions
2 sponsors
1 location
NCT05682235
Therapeutic Exercise and Education in Pain Neurophysiology to Improve Pain Intensity in Women With Endometriosis. Clinical Trial.
NA
Active, not recruiting
40 participants
Started: Dec 12, 2022 · Completed: Mar 12, 2025
1 condition
1 sponsor
1 location
NCT05662345
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
N/A
Active, not recruiting
65 participants
Started: Dec 12, 2022 · Completed: Oct 30, 2026
1 condition
2 sponsors
4 locations
NCT06100354
Study of Patient Preferences in Relation to the Fitting of a Personalized and Connected Joint Prosthesis.
N/A
Active, not recruiting
200 participants
Started: Dec 12, 2022 · Completed: Jun 12, 2025
2 conditions
1 sponsor
1 location
NCT05682742
Clinical Investigation of the da Vinci Surgical System
NA
Active, not recruiting
53 participants
Started: Dec 12, 2022 · Completed: Aug 31, 2028
10 conditions
1 sponsor
4 locations
NCT05747443
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
NA
Active, not recruiting
1,837 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT05480462
Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
PHASE3
Active, not recruiting
200 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2024
2 conditions
1 sponsor
2 locations
NCT05481476
Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer
PHASE2
Active, not recruiting
32 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06212141
Comparison of Bulk-Fill Composite Resins in Class II Restorations
NA
Active, not recruiting
54 participants
Started: Dec 12, 2022 · Completed: Jun 15, 2024
1 condition
1 sponsor
1 location
NCT05677763
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
PHASE4
Active, not recruiting
525 participants
Started: Dec 12, 2022 · Completed: Sep 28, 2026
2 conditions
1 sponsor
42 locations
NCT05102721
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
PHASE1/PHASE2
Active, not recruiting
48 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT05562882
A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia
PHASE2
Active, not recruiting
60 participants
Started: Dec 10, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04196556
Effectiveness of an Intervention Programme for Childhood Obesity: FAMILIACT
NA
Active, not recruiting
253 participants
Started: Dec 10, 2022 · Completed: Dec 14, 2024
1 condition
1 sponsor
1 location
NCT05513001
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
PHASE3
Active, not recruiting
696 participants
Started: Dec 9, 2022 · Completed: Aug 2, 2027
1 condition
1 sponsor
207 locations
NCT05263583
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
PHASE2
Active, not recruiting
14 participants
Started: Dec 9, 2022 · Completed: Jun 30, 2025
9 conditions
1 sponsor
11 locations
NCT05394168
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
PHASE1
Active, not recruiting
12 participants
Started: Dec 9, 2022 · Completed: Mar 4, 2025
1 condition
1 sponsor
1 location
NCT05630612
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
PHASE2
Active, not recruiting
32 participants
Started: Dec 8, 2022 · Completed: Sep 1, 2027
3 conditions
2 sponsors
1 location
NCT05546242
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals
PHASE3
Active, not recruiting
540 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
7 locations
NCT05610163
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
PHASE2
Active, not recruiting
783 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2033
3 conditions
2 sponsors
685 locations
NCT05515536
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
PHASE3
Active, not recruiting
130 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
14 locations
NCT05090033
Characterizing the Use of Ofatumumab in a Real World Setting
N/A
Active, not recruiting
103 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
PHASE1
Active, not recruiting
89 participants
Started: Dec 8, 2022 · Completed: Apr 11, 2027
5 conditions
1 sponsor
26 locations
NCT05650190
Spectacle Lens Visual Acuity Assessments Study
NA
Active, not recruiting
51 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
6 locations
NCT05432583
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
PHASE1
Active, not recruiting
318 participants
Started: Dec 8, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
6 locations
NCT05647161
BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)
NA
Active, not recruiting
34 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT05359211
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
PHASE1
Active, not recruiting
28 participants
Started: Dec 8, 2022 · Completed: Sep 4, 2026
9 conditions
2 sponsors
1 location
NCT04756401
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
52 participants
Started: Dec 8, 2022 · Completed: Dec 30, 2027
2 conditions
2 sponsors
4 locations
NCT05543889
Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists
N/A
Active, not recruiting
163 participants
Started: Dec 7, 2022 · Completed: Mar 7, 2024
1 condition
1 sponsor
1 location
NCT05905796
The Brain Health Study: A Pragmatic, Patient-Centered Trial
NA
Active, not recruiting
1,350 participants
Started: Dec 7, 2022 · Completed: Oct 5, 2025
2 conditions
3 sponsors
3 locations
Previous
1
More pages
148
149
150
151
152
153
154
More pages
431
Next